ELRiSE MDS

A Phase 3, Multicenter, Open-Label, Randomized Trial to Compare the Efficacy and Safety of Elritercept Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in ESA-naïve Adult Participants Who Require Red Blood Cell Transfusions

Near Add Your Location

Sorting 28 by

MDS Center of Excellence

  • Not yet accepting
  • Not yet accepting

MDS Center of Excellence

  • Not yet accepting

MDS Center of Excellence

Fox Chase Cancer Center
Temple Health
Philadelphia, PA
  • Not yet accepting

MDS Center of Excellence

  • Not yet accepting
  • Not yet accepting

MDS Center of Excellence

Vanderbilt-Ingram Cancer Center
Henry-Joyce Cancer Clinic
Nashville, TN
  • Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.